To overcome these limitations, autologous T cells may be replaced by allogeneic T cells from healthy donors, which through knock-out the endogenous TCR and B2M genes of T cells to avoid the occurrence of graft-versus-host disease (GvHD) [20–23]. The gene discussed is B2M; the disease is graft versus host disease.